Encouraging Results Have Been Announced From a Trial of an Investigational Treatment For BPDCN
kkolosov / Pixabay

Encouraging Results Have Been Announced From a Trial of an Investigational Treatment For BPDCN

Results from research into an experimental therapy called SL-401 for the treatment of patients with blastic plasmacytoid dendritic cell neoplasm have been shared at the Congress of the European Haematology…

Continue Reading Encouraging Results Have Been Announced From a Trial of an Investigational Treatment For BPDCN
Kalytera Therapeutics Will Meet with the FDA to Discuss Cannabidiol as a Possible Treatment For Acute GVHD
889520 / Pixabay

Kalytera Therapeutics Will Meet with the FDA to Discuss Cannabidiol as a Possible Treatment For Acute GVHD

Kalytera Therapeutics, Inc. has announced that a meeting with the Centre for Drug Evaluation and Research of the US FDA is planned for Tuesday, 31st July this year. The purpose of…

Continue Reading Kalytera Therapeutics Will Meet with the FDA to Discuss Cannabidiol as a Possible Treatment For Acute GVHD
Could Virtual Reality Cure Glaucoma?
Source: Pixabay

Could Virtual Reality Cure Glaucoma?

According to a story published by STAT, a daredevil neuroscientist at Stanford University is utilizing the relatively new concept of virtual reality to solve an unsuspecting problem. Not only is…

Continue Reading Could Virtual Reality Cure Glaucoma?

BrainStorm Has Secured a Second Manufacturing Facility for NurOwn, an Experimental Drug for ALS

BrainStorm Cell Therapeutics Inc. has announced that it has secured its second U.S. manufacturing location for NurOwn®, an experimental drug currently under investigation for the treatment of amyotrophic lateral sclerosis…

Continue Reading BrainStorm Has Secured a Second Manufacturing Facility for NurOwn, an Experimental Drug for ALS

A New Treatment for Dupuytren’s Contracture Could Improve Outcomes

According to a story from the Deccan Chronicle, researchers may have discovered a new treatment for Dupuytren's contracture that could offer substantial benefits over currently available treatment options. The scientists…

Continue Reading A New Treatment for Dupuytren’s Contracture Could Improve Outcomes

First Hemophilia B Patient Enrolled in Potential Breakthrough Phase III Trial

According to BioPortfolio, the company UniQure has recently announced that the first hemophilia B patient has been enrolled in their Phase III study of the treatment AMT-061, which is an…

Continue Reading First Hemophilia B Patient Enrolled in Potential Breakthrough Phase III Trial
Study Offers Free Screening for Cancer and BRCA Mutations for Ashkenazi Jewish Community
JoshMB / Pixabay

Study Offers Free Screening for Cancer and BRCA Mutations for Ashkenazi Jewish Community

According to a story from Jewish Community Voice, the BRCA Founder Outreach Study, which is a national, cancer-focused research study, is offering free screenings for people of Ashkenazi Jewish descent.…

Continue Reading Study Offers Free Screening for Cancer and BRCA Mutations for Ashkenazi Jewish Community
Scientists Have Discovered a Mechanism Behind Hypokalemic Periodic Paralysis
source: pixabay.com

Scientists Have Discovered a Mechanism Behind Hypokalemic Periodic Paralysis

According to a story from sciencedaily.com, recent research has revealed the mechanism that causes hypokalemic periodic paralysis, a rare condition that causes patients to experience sudden, severe muscle weakness. The…

Continue Reading Scientists Have Discovered a Mechanism Behind Hypokalemic Periodic Paralysis